Pomanda estimates the enterprise value of CANCER CENTRE LONDON LLP at £0 based on a Turnover of £17m and 0x industry multiple (adjusted for size and gross margin).
cancer centre london llpEstimated Valuation
£0
Pomanda estimates the enterprise value of CANCER CENTRE LONDON LLP at £0 based on an EBITDA of £1.7m and a 0x industry multiple (adjusted for size and gross margin).
cancer centre london llpEstimated Valuation
£0
Pomanda estimates the enterprise value of CANCER CENTRE LONDON LLP at £0 based on Net Assets of £2.3m and 0x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Cancer Centre London LlpOverview
Cancer Centre London Llp is a live company located in corsham, SN13 9FU with a Companies House number of OC352271. Founded in February 2010, it's largest shareholder is
unknown.
Cancer Centre London Llp is a established,
mid sized company, Pomanda has estimated its turnover at
£17m with
healthy
growth in recent years.
There is insufficient data available to calculate a health check for Cancer Centre London Llp. Company Health Check FAQs
Health Rating0out of 5
0 Strong
0 Regular
0 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Cancer Centre London Llp
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- - Cancer Centre London Llp
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Cancer Centre London Llp
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Cancer Centre London Llp
- - Industry AVG
Employees
There is insufficient data available for this Key Performance Indicator!
- - Cancer Centre London Llp
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- - Cancer Centre London Llp
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- - Cancer Centre London Llp
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Cancer Centre London Llp
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Cancer Centre London Llp
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Cancer Centre London Llp
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Cancer Centre London Llp
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Cancer Centre London Llp
- - Industry AVG
CANCER CENTRE LONDON LLP financials
EXPORT
Cancer Centre London Llp's latest turnover from December 2023 is £17 million and the company has net assets of £2.3 million. According to their latest financial statements, Cancer Centre London Llp has 59 employees and maintains cash reserves of £1 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Turnover
16,979,000
15,534,000
13,943,000
13,702,000
14,496,000
12,952,000
13,212,000
11,423,000
10,320,000
9,211,000
8,206,000
8,129,000
7,764,000
6,321,000
Other Income Or Grants
Cost Of Sales
11,565,000
10,594,000
10,322,000
9,506,000
9,800,000
8,461,000
8,212,000
Gross Profit
5,414,000
4,940,000
3,621,000
4,196,000
4,696,000
4,491,000
5,000,000
Admin Expenses
3,974,000
3,388,000
1,874,000
1,979,000
2,086,000
-2,788,000
-3,229,000
-2,730,000
-2,162,000
-2,009,000
-1,954,000
-1,900,000
Operating Profit
1,440,000
1,552,000
1,747,000
2,217,000
2,610,000
4,491,000
5,000,000
2,788,000
3,229,000
2,730,000
2,162,000
2,009,000
1,954,000
1,900,000
Interest Payable
4,000
25,000
43,000
67,000
160,000
160,000
Interest Receivable
Pre-Tax Profit
1,440,000
1,548,000
1,722,000
2,174,000
2,543,000
1,916,000
2,533,000
2,192,000
2,608,000
1,215,000
751,000
412,000
384,000
613,000
Tax
-160,000
-160,000
Profit After Tax
1,440,000
1,548,000
1,722,000
2,174,000
2,543,000
1,756,000
2,373,000
2,192,000
2,608,000
1,215,000
751,000
412,000
384,000
613,000
Dividends Paid
Retained Profit
542,000
616,000
1,722,000
2,174,000
2,543,000
319,000
917,000
856,000
2,608,000
1,215,000
751,000
412,000
384,000
613,000
Employee Costs
2,251,000
2,152,000
2,183,000
2,253,000
2,489,000
2,606,000
2,279,000
2,101,000
2,011,000
1,969,000
1,856,000
1,944,000
1,909,000
1,387,000
Number Of Employees
59
61
65
72
78
98
76
68
51
50
45
50
50
47
EBITDA*
1,663,000
1,735,000
2,218,000
2,712,000
3,063,000
4,885,000
5,390,000
2,845,000
3,286,000
2,787,000
2,219,000
2,066,000
1,954,000
1,900,000
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Tangible Assets
516,000
393,000
114,000
528,000
966,000
759,000
1,096,000
Intangible Assets
336,000
291,000
450,000
507,000
564,000
621,000
678,000
735,000
792,000
849,000
906,000
963,000
1,020,000
1,092,000
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
852,000
684,000
564,000
1,035,000
1,530,000
1,380,000
1,774,000
735,000
792,000
849,000
906,000
963,000
1,020,000
1,092,000
Stock & work in progress
1,055,000
893,000
1,300,000
1,113,000
795,000
822,000
940,000
571,000
709,000
535,000
366,000
433,000
298,000
383,000
Trade Debtors
1,374,000
1,899,000
1,265,000
1,392,000
1,128,000
1,176,000
1,040,000
1,530,000
1,289,000
1,085,000
964,000
847,000
601,000
906,000
Group Debtors
201,000
201,000
201,000
Misc Debtors
1,697,000
272,000
113,000
63,000
39,000
11,000
27,000
Cash
1,000
1,000
1,000
26,000
49,000
6,000
7,000
18,000
22,000
22,000
11,000
375,000
375,000
360,000
misc current assets
total current assets
4,127,000
3,065,000
2,566,000
2,531,000
2,286,000
2,268,000
2,227,000
2,119,000
2,031,000
1,642,000
1,341,000
1,655,000
1,301,000
1,649,000
total assets
4,979,000
3,749,000
3,130,000
3,566,000
3,816,000
3,648,000
4,001,000
2,854,000
2,823,000
2,491,000
2,247,000
2,618,000
2,321,000
2,741,000
Bank overdraft
Bank loan
Trade Creditors
1,007,000
933,000
2,590,000
Group/Directors Accounts
883,000
1,005,000
1,943,000
1,607,000
1,303,000
953,000
635,000
1,087,000
821,000
1,199,000
other short term finances
hp & lease commitments
62,000
397,000
438,000
336,000
other current liabilities
750,000
865,000
1,998,000
2,271,000
2,114,000
73,000
18,000
52,000
31,000
42,000
total current liabilities
2,640,000
2,803,000
2,060,000
2,668,000
2,552,000
2,590,000
2,279,000
1,680,000
1,303,000
971,000
687,000
1,118,000
821,000
1,241,000
loans
124,000
262,000
1,056,000
hp & lease commitments
62,000
131,000
528,000
460,000
760,000
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
62,000
131,000
528,000
460,000
760,000
total liabilities
2,640,000
2,803,000
2,122,000
2,799,000
3,080,000
3,050,000
3,039,000
1,680,000
1,303,000
971,000
687,000
1,118,000
821,000
1,241,000
net assets
2,339,000
946,000
1,008,000
767,000
736,000
598,000
962,000
1,174,000
1,520,000
1,520,000
1,560,000
1,500,000
1,500,000
1,500,000
total shareholders funds
2,339,000
946,000
1,008,000
767,000
736,000
598,000
962,000
1,174,000
1,520,000
1,520,000
1,560,000
1,500,000
1,500,000
1,500,000
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Operating Activities
Operating Profit
1,440,000
1,552,000
1,747,000
2,217,000
2,610,000
4,491,000
5,000,000
2,788,000
3,229,000
2,730,000
2,162,000
2,009,000
1,954,000
1,900,000
Depreciation
166,000
126,000
414,000
438,000
396,000
337,000
333,000
Amortisation
57,000
57,000
57,000
57,000
57,000
57,000
57,000
57,000
57,000
57,000
57,000
57,000
Tax
-160,000
-160,000
Stock
162,000
-407,000
187,000
318,000
-27,000
-118,000
369,000
-138,000
174,000
169,000
-67,000
135,000
-85,000
383,000
Debtors
900,000
906,000
-127,000
-50,000
2,000
160,000
-250,000
230,000
215,000
121,000
117,000
219,000
-278,000
906,000
Creditors
74,000
933,000
-2,590,000
2,590,000
Accruals and Deferred Income
-115,000
-1,133,000
-273,000
157,000
2,114,000
-73,000
73,000
-18,000
-34,000
21,000
31,000
-42,000
42,000
Deferred Taxes & Provisions
Cash flow from operations
560,000
1,036,000
1,885,000
2,601,000
2,612,000
7,273,000
5,038,000
2,826,000
2,879,000
2,463,000
2,190,000
1,743,000
2,275,000
653,000
Investing Activities
capital expenditure
-391,000
-303,000
-603,000
-1,429,000
72,000
-1,092,000
Change in Investments
cash flow from investments
-391,000
-303,000
-603,000
-1,429,000
72,000
-1,092,000
Financing Activities
Bank loans
Group/Directors Accounts
-122,000
1,005,000
-1,943,000
336,000
304,000
350,000
318,000
-452,000
266,000
-378,000
1,199,000
Other Short Term Loans
Long term loans
-124,000
-138,000
-794,000
1,056,000
Hire Purchase and Lease Commitments
-124,000
-404,000
-438,000
506,000
-636,000
1,096,000
other long term liabilities
share issue
851,000
-678,000
-1,481,000
-2,143,000
-2,405,000
-683,000
-1,129,000
-1,202,000
-2,608,000
-1,255,000
-691,000
-412,000
-384,000
887,000
interest
-4,000
-25,000
-43,000
-67,000
-160,000
-160,000
cash flow from financing
729,000
75,000
-2,048,000
-3,418,000
-910,000
-3,422,000
143,000
-898,000
-2,258,000
-937,000
-1,143,000
-146,000
-762,000
2,086,000
cash and cash equivalents
cash
-25,000
-23,000
43,000
-1,000
-11,000
-4,000
11,000
-364,000
15,000
360,000
overdraft
change in cash
-25,000
-23,000
43,000
-1,000
-11,000
-4,000
11,000
-364,000
15,000
360,000
cancer centre london llp Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for cancer centre london llp. Get real-time insights into cancer centre london llp's credit score, group structure and payment trends.
Perform a competitor analysis for cancer centre london llp by selecting its closest rivals, whether from the industry sector, other mid companies, companies in SN13 area or any other competitors across 12 key performance metrics.
cancer centre london llp Ownership
CANCER CENTRE LONDON LLP group structure
Cancer Centre London Llp has no subsidiary companies.
Ultimate parent company
CANCER CENTRE LONDON LLP
OC352271
CANCER CENTRE LONDON LLP Shareholders
The sole shareholder of Cancer Centre London Llp is -.
-
-
cancer centre london llp directors
Cancer Centre London Llp currently has 1 director, Dr Charlotte Rayner serving since Mar 2010.
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023
net assets
2.3m
+1.47%
total assets
5m
+0.33%
cash
1k
0%
net assets
Total assets minus all liabilities
Similar Companies
Similar companies unavailable for this selection
cancer centre london llp company details
company number
OC352271
Type
Other
industry
incorporation date
February 2010
age
15
incorporated
UK
ultimate parent company
None
accounts
Full Accounts
last accounts submitted
December 2023
previous names
parkside oncology clinic llp (November 2010)
accountant
-
auditor
DELOITTE LLP
address
3 corsham science park, park lane, corsham, wiltshire, SN13 9FU
Bank
-
Legal Advisor
-
cancer centre london llp Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to cancer centre london llp.
cancer centre london llp Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for CANCER CENTRE LONDON LLP. This can take several minutes, an email will notify you when this has completed.
cancer centre london llpCompanies House Filings - See Documents
